thiophenes has been researched along with virginiamycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arisawa, M; Kudoh, T; Kuwahara, T; Nagase, H; Nakano, A; Takamiya, M; Yoshizaki, H | 1 |
| Appelbaum, PC; Bogdanovich, T; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P | 1 |
2 other study(ies) available for thiophenes and virginiamycin
| Article | Year |
|---|---|
Species specificity of pharmacological characteristics of CCK-B receptors.
Topics: Aged; Animals; Brain Chemistry; Cholecystokinin; Furans; Guanylyl Imidodiphosphate; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Membranes; Mice; Pancreas; Rats; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Species Specificity; Thiophenes; Virginiamycin | 1993 |
Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pyridines; Staphylococcus aureus; Thienopyridines; Thiophenes; Virginiamycin | 2007 |